DSDivya Srivastava

Divya Srivastava

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Divya Srivastava has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring Healthcare Providers’ Expectations and Perceptions of AI Machine Learning Decision Tree Models in Healthcare

    by Bas Luka Hendrik Laan, Linda Peute, Divya Srivastava

    This paper investigates healthcare policymakers’ and professionals’ perceptions of Artificial Intelligence (AI) Machine Learning (ML) Decision Tree Models and their potential effects on clinical work processes. Semi-structured interviews with Dutch participants revealed nine key themes and 16 subthemes. Findings indicate that AI models are seen as supportive tools that can enhance care quality by automating repetitive tasks, freeing up time for patient-centred care. However, there is scepticism about significant time savings and increased patient turnover. Both groups emphasise the need for seamless integration with existing systems and comprehensive training to mitigate risks and improve adoption.

  • Open Access

    Did COVID-19 reduce the digital divide? A systematic review

    by Georgina Connolly, Joan Costa-Font, Divya Srivastava


  • Open Access

    From Theory to Practice: Viewpoint on Economic Indicators for Trust in Digital Health

    by Felix Gille, Laura Maaß, Benjamin Ho, Divya Srivastava

    User trust is pivotal for the adoption of digital health systems interventions (DHI). In response, numerous trust-building guidelines have recently emerged targeting DHIs such as artificial intelligence. The common aim of these guidelines aimed at private sector actors and government policy makers is to build trustworthy DHI. While these guidelines provide some indication of what trustworthiness is, the guidelines typically only define trust and trustworthiness in broad terms, they rarely offer guidance about economic considerations that would allow implementers to measure and balance trade-offs between costs and benefits. These considerations are important when deciding how best to allocate scarce resources (eg, financial capital, workforce, or time). The missing focus on economics undermines the potential usefulness of such guidelines. We propose the development of actionable trust-performance-indicators (including but not limited to surveys) to gather evidence on the cost-effectiveness of trust-building principles as a crucial step for successful implementation. Furthermore, we offer guidance on navigating the conceptual complexity surrounding trust and on how to sharpen the trust discourse. Successful implementation of economic considerations is critical to successfully build user trust in DHI.


  • Open Access

    AI: A Use Case for Global Health

    by Divya Srivastava

    The LSE Public Policy Review is an open-access, refereed journal which is published quarterly. Each issue is thematic and concentrates on a key topic at the heart of current debates in public policy. Public policy challenges bring to the fore cross-cutting questions which require a global perspective and a focus on their interconnectedness. Because of this, articles in each issue take different disciplinary perspectives, encouraging interdisciplinary collaboration and analysis at the forefront of current thinking. As a result, each issue presents a comprehensive approach to the specific theme and an analysis that is academically rigorous but also readily accessible to all readers. The LSEPPR publishes original research papers, conceptual articles, review papers written for a general readership, in non-technical language aimed at a wide audience including government, business and policy-makers, as well as academics and students. LSEPPR seeks to actively contribute to the study and development of public and social policy, public administration and public management.


  • Open Access

    From Theory to Practice: Viewpoint on Economic Indicators for Trust in Digital Health (Preprint)

    by Felix Gille, Laura Maaß, Benjamin Ho, Divya Srivastava

    UNSTRUCTURED User trust is pivotal for the adoption of digital health systems interventions (DHI). In response, numerous trust-building guidelines have recently emerged targeting DHIs such as artificial intelligence. The common aim of these guidelines aimed at private sector actors and government policy makers is to build trustworthy DHI. While these guidelines provide some indication of what trustworthiness is, the guidelines typically only define trust and trustworthiness in broad terms, they rarely offer guidance about economic considerations that would allow implementers to measure and balance trade-offs between costs and benefits. These considerations are important when deciding how best to allocate scarce resources (eg, financial capital, workforce, or time). The missing focus on economics undermines the potential usefulness of such guidelines. We propose the development of actionable trust-performance-indicators (including but not limited to surveys) to gather evidence on the cost-effectiveness of trust-building principles as a crucial step for successful implementation. Furthermore, we offer guidance on navigating the conceptual complexity surrounding trust and on how to sharpen the trust discourse. Successful implementation of economic considerations is critical to successfully build user trust in DHI.


  • Open Access

    A Framework for Digital Health Policy: Insights from Virtual Primary Care Systems Across Five Nations

    by Divya Srivastava, Robin Van Kessel, Marine Delgrange, Avi Cherla, Harpreet Sood, Elias Mossialos

    Digital health technologies used in primary care, referred to as, virtual primary care, allow patients to interact with primary healthcare professionals remotely though the current iteration of virtual primary care may also come with several unintended consequences, such as accessibility barriers and cream skimming. The World Health Organization (WHO) has a well-established framework to understand the functional components of health systems. However, the existing building blocks framework does not sufficiently account for the disruptive and multi-modal impact of digital transformations. In this review, we aimed to develop the first iteration of this updated framework by reviewing the deployment of virtual primary care systems in five leading countries: Canada, Finland, Germany and Sweden and the United Kingdom (England). We found that all five countries have taken different approaches with the deployment of virtual primary care, yet seven common themes were highlighted across countries: (1) stated policy objectives, (2) regulation and governance, (3) financing and reimbursement, (4) delivery and integration, (5) workforce training and support, (6) IT systems and data sharing, and (7) the extent of patient involvement in the virtual primary care system. The conceptual framework that was derived from these findings offers a set of guiding principles that can facilitate the assessment of virtual primary care in health system settings.


  • Top Cited Papers
    Open Access

    Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping

    by Robin van Kessel, Divya Srivastava, Ilias Kyriopoulos, Giovanni Monti, David Novillo-Ortiz, Ran Milman, Wojciech Wilhelm Zhang-Czabanowski, Greta Nasi, Ariel Dora Stern, George Wharton, et al.

    Background: The adoption of digital health care within health systems is determined by various factors, including pricing and reimbursement. The reimbursement landscape for digital health in Europe remains underresearched. Although various emergency reimbursement decisions were made during the COVID-19 pandemic to enable health care delivery through videoconferencing and asynchronous care (eg, digital apps), research so far has primarily focused on the policy innovations that facilitated this outside of Europe. Objective: This study examines the digital health reimbursement strategies in 8 European countries (Belgium, France, Germany, Italy, the Netherlands, Poland, Sweden, and the United Kingdom) and Israel. Methods: We mapped available digital health reimbursement strategies using a scoping review and policy mapping framework. We reviewed the literature on the MEDLINE, Embase, Global Health, and Web of Science databases. Supplementary records were identified through Google Scholar and country experts. Results: Our search strategy yielded a total of 1559 records, of which 40 (2.57%) were ultimately included in this study. As of August 2023, digital health solutions are reimbursable to some extent in all studied countries except Poland, although the mechanism of reimbursement differs significantly across countries. At the time of writing, the pricing of digital health solutions was mostly determined through discussions between national or regional committees and the manufacturers of digital health solutions in the absence of value-based assessment mechanisms. Financing digital health solutions outside traditional reimbursement schemes was possible in all studied countries except Poland and typically occurs via health innovation or digital health–specific funding schemes. European countries have value-based pricing frameworks that range from nonexistent to embryonic. Conclusions: Studied countries show divergent approaches to the reimbursement of digital health solutions. These differences may complicate the ability of patients to seek cross-country health care in another country, even if a digital health app is available in both countries. Furthermore, the fragmented environment will present challenges for developers of such solutions, as they look to expand their impact across countries and health systems. An increased emphasis on developing a clear conceptualization of digital health, as well as value-based pricing and reimbursement mechanisms, is needed for the sustainable integration of digital health. This study can therein serve as a basis for further, more detailed research as the field of digital health reimbursement evolves.


  • Open Access

    Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus framework

    by Divya Srivastava, Cornelia Henschke, Lotta Virtanen, Eno-Martin Lotman, Rocco Friebel, Vittoria Ardito, Francesco Petracca

    Despite the acceleration in the use of digital health technologies across different aspects of the healthcare system, the full potential of real-world data (RWD) and real-world evidence (RWE) arising from the technologies is not being utilised in decision-making. We examine current national efforts and future opportunities to systematically use RWD and RWE in decision-making in five countries (Estonia, Finland, Germany, Italy and the United Kingdom), and then develop a framework for promotion of the systematic use of RWD and RWE. A review assesses current national efforts, complemented with a three-round consensus-building exercise among an international group of experts (n1 = 44,n2 = 24,n3 = 24) to derive key principles. We find that Estonia and Finland have invested and developed digital health-related policies for several years; Germany and Italy are the more recent arrivals, while the United Kingdom falls somewhere in the middle. Opportunities to promote the systematic use of RWD and RWE were identified for each country. Eight building blocks principles were agreed through consensus, relating to policy scope, institutional role and data collection. Promoting post-market surveillance and digital health technology vigilance ought to rely on clarity in scope and data collection with consensus reached on eight principles to leverage RWD and RWE.


  • Open Access

    The inclusion of diagnostics in national health insurance schemes in Cambodia, India, Indonesia, Nepal, Pakistan, Philippines and Viet Nam

    by Jacob Bigio, Emma Hannay, Madhukar Pai, Bachti Alisjahbana, Rishav Das, Huy Ba Huynh, Uzma Khan, Lalaine Mortera, Thu Anh Nguyen, Muhammad Aamir Safdar, et al.

    The Lancet Commission on Diagnostics highlighted a huge gap in access to diagnostic testing even for basic tests, particularly at the primary care level, and emphasised the need for countries to include diagnostics as part of their universal health coverage benefits packages. Despite the poor state of diagnostic-related services in low-income and middle-income countries (LMICs), little is known about the extent to which diagnostics are included in the health benefit packages. We conducted an analysis of seven Asian LMICs—Cambodia, India, Indonesia, Nepal, Pakistan, Philippines, Viet Nam—to understand this issue. We conducted a targeted review of relevant literature and applied a health financing framework to analyse the benefit packages available in each government-sponsored scheme. We found considerable heterogeneity in country approaches to diagnostics. Of the seven countries, only India has developed a national essential diagnostics list. No country presented a clear policy rationale on the inclusion of diagnostics in their scheme and the level of detail on the specific diagnostics which are covered under the schemes was also generally lacking. Government-sponsored insurance expansion in the eligible populations has reduced the out-of-pocket health payment burden in many of the countries but overall, there is a lack of access, availability and affordability for diagnostic-related services.


  • Open Access

    Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping (Preprint)

    by Robin van Kessel, Divya Srivastava, Ilias Kyriopoulos, Giovanni Monti, David Novillo-Ortiz, Ran Milman, Wojciech Wilhelm Zhang-Czabanowski, Greta Nasi, Ariel Dora Stern, George Wharton, et al.

    BACKGROUND The adoption of digital health care within health systems is determined by various factors, including pricing and reimbursement. The reimbursement landscape for digital health in Europe remains underresearched. Although various emergency reimbursement decisions were made during the COVID-19 pandemic to enable health care delivery through videoconferencing and asynchronous care (eg, digital apps), research so far has primarily focused on the policy innovations that facilitated this outside of Europe. OBJECTIVE This study examines the digital health reimbursement strategies in 8 European countries (Belgium, France, Germany, Italy, the Netherlands, Poland, Sweden, and the United Kingdom) and Israel. METHODS We mapped available digital health reimbursement strategies using a scoping review and policy mapping framework. We reviewed the literature on the MEDLINE, Embase, Global Health, and Web of Science databases. Supplementary records were identified through Google Scholar and country experts. RESULTS Our search strategy yielded a total of 1559 records, of which 40 (2.57%) were ultimately included in this study. As of August 2023, digital health solutions are reimbursable to some extent in all studied countries except Poland, although the mechanism of reimbursement differs significantly across countries. At the time of writing, the pricing of digital health solutions was mostly determined through discussions between national or regional committees and the manufacturers of digital health solutions in the absence of value-based assessment mechanisms. Financing digital health solutions outside traditional reimbursement schemes was possible in all studied countries except Poland and typically occurs via health innovation or digital health–specific funding schemes. European countries have value-based pricing frameworks that range from nonexistent to embryonic. CONCLUSIONS Studied countries show divergent approaches to the reimbursement of digital health solutions. These differences may complicate the ability of patients to seek cross-country health care in another country, even if a digital health app is available in both countries. Furthermore, the fragmented environment will present challenges for developers of such solutions, as they look to expand their impact across countries and health systems. An increased emphasis on developing a clear conceptualization of digital health, as well as value-based pricing and reimbursement mechanisms, is needed for the sustainable integration of digital health. This study can therein serve as a basis for further, more detailed research as the field of digital health reimbursement evolves.